Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 14, 2020; 26(14): 1660-1673
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1660
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1660
Figure 2 Receiver operating characteristic curve generated for the capacity of macrophage inhibitory cytokine-1 or growth differentiation factor-15 to predict abnormal endoscopic ultrasound results.
A: Abnormal endoscopic ultrasound (AUC = 0.576, 95%CI: 0.454-0.698, P = 0.234); B: Branched duct intraductal papillary mucinous neoplasm (AUC = 0.664, 95%CI: 0.414-0.875, P = 0.223); C: Pancreatic cyst (AUC = 0.347, 95%CI: 0.162-0.532, P = 0.131); D: Diffuse abnormality (AUC = 0.510, 95%CI: 0.254-0.764, P = 0.935). ROC: Receiver operating characteristic.
- Citation: O’Neill RS, Emmanuel S, Williams D, Stoita A. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort. World J Gastroenterol 2020; 26(14): 1660-1673
- URL: https://www.wjgnet.com/1007-9327/full/v26/i14/1660.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i14.1660